Mostafa Eysha, oncologist at Texas Tech University Health Sciences Center El Paso, shared a post on LinkedIn:
“I am thrilled to announce that our research team will be presenting at ASCO26! It has been an incredible year of collaborating on impactful clinical research, and I am incredibly proud to share that we will be presenting one Oral Abstract and four poster sessions highlighting our latest clinical findings across hematology and oncology.
If you are attending, please stop by and connect with us at the following sessions:
Oral Abstract Session: Quality Care/Health Services Research
Title: Impact of mRNA SARS-CoV-2 Vaccination on CAR T-Cell Therapy Outcomes in Hematologic Malignancies: A Multi-Center Real-World Analysis (Abstract 11001)
Presenter: Jowan Al-Nusair
When: Sunday, May 31 | 8:00–11:00 AM CT (Presentation Time: 8:24–8:36 AM)
Where: Location S100bc
Poster Sessions:
Impact of COVID-19 mRNA vaccines on survival outcomes in patients with solid tumors receiving immunotherapy: A large-scale retrospective study
Presenter: Mariah Black
When: Saturday, May 30 | 1:00–4:30 PM CT
Poster Board: 427
Real-world overall survival outcomes of BTK inhibitors vs. Venetoclax-based therapy as second line treatment for Chronic Lymphocytic Leukemia
Presenter: Mariah Black
When: Monday, June 1 | 9:00 AM–12:00 PM CT
Poster Board: 550
Dual HER2 Blockade with or without taxane induction in HR+/HER2+ metastatic breast cancer: A comparative analysis of clinical outcomes
Presenter: Mariah Black
When: Monday, June 1 | 1:30–4:30 PM CT
Poster Board: 173
The impact of COVID‑19 mRNA vaccination on bispecific antibody outcomes in hematologic malignancies: A retrospective multicenter cohort study
Presenter: Mostafa Eysha
When: Monday, June 1 | 9:00 AM–12:00 PM CT
Poster Board: 538.
A huge thank you to my amazing co-authors and research collaborators for their immense dedication to these projects and to advancing patient care. I want to give a special shoutout to our presenters: Jowan Al-Nusair, who is an upcoming HemOnc fellow at Moffitt Cancer Center, and Mariah Black, who is heading to the University of Arizona as an incoming resident! It is an honor to work alongside you both, as well as Bayan Khasawneh, Rafik ElBeblawy, and the rest of the team.
I also want to express my deepest gratitude to my incredible mentors M. Bilal Abid, Jose Conejo-Garcia, Ahmed Elkhanany, and Nicholas DeVito. Thank you for your continued leadership, guidance, and support throughout this journey.
I am looking forward to connecting with fellow clinicians and researchers to discuss these outcomes. See you in Chicago!”
Other articles about ASCO on OncoDaily.